Tue, Jul 25, 2023
The approval granted by the US Food & Drug Administration (USFDA) is to manufacture and market Plerixafor Injection of strengths 24 mg/1.2 mL (20 mg/mL), single-dose vial, Aurobindo Pharma said in a regulatory filing.
More >
Fri, Jun 23, 2023
Aurobindo Pharma news: Aurobindo Pharma on Friday said its wholly-owned arm, Eugia Pharma Specialities Ltd has entered into a voluntary sub-licensing agreement with Medicines Patent Pool (MPP) to develop and market an anti-cancer drug.
Fri, Apr 21, 2023
Stocks to buy today (April 21), Pick of the Day, Stocks to invest in today: In conversation with Zee Business Managing Editor Anil Singhvi, market experts Kunal Saraogi, Rakesh Bansal, Sacchitanand Uttekar and Sumeet Bagadia share their top recommendations for the day in this special segment, Pick of the Day.
Mon, Nov 14, 2022
Aurobindo Pharma Share Price: Aurobindo Pharma Vice-Chairman and Managing Director K Nithyananda Reddy said the company's second quarter performance was subdued, mainly due to macro-environment factors and higher competitive intensity for some products in the US.
Thu, Nov 10, 2022
Why share of Aurbindo Pharma has register fall? Why did it fall more than 10%? Know full details from Nupur.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
